Alyeska Investment Group’s CVRx CVRX Stock Holding History

Alyeska Investment Group’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-75,000	Closed	-$2.1M	–	700
2021 Q2	$2.1M	Buy	+75,000	New	+$2.1M	0.02%	504

Other funds holding CVRX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Alyeska Investment Group's CVRX Position: Q3 2021 in Review

Alyeska Investment Group sold out of CVRx (CVRX) in Q3 2021, closing a stake of 75,000 shares — an estimated $2.1M sold.

Alyeska Investment Group first reported a position in CVRX in Q2 2021 and held it in 1 quarter. The position peaked at $2.1M in Q2 2021. 50 funds tracked by Wall St. Rank hold CVRX as of Q3 2021.

Alyeska Investment Group reported no remaining CVRx position as of Q3 2021 after selling out during the quarter.
Alyeska Investment Group sold 75,000 CVRx shares in Q3 2021, an estimated $2.1M.
Alyeska Investment Group first reported a position in CVRx in Q2 2021 and held it in 1 quarter.
Alyeska Investment Group's CVRx position peaked at $2.1M in Q2 2021.
50 funds tracked by Wall St. Rank held CVRx as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.